Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$11.96
Previous CloseN/A
Volume18.00K
Average Volume (3M)1.48M
Market Cap
HK$972.89M
Enterprise ValueHK$5.81K
Total Cash (Recent Filing)HK$551.05M
Total Debt (Recent Filing)HK$1.93B
Price to Earnings (P/E)23.9
Beta0.58
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,621,488,000
10 Day Avg. Volume1,443,300
30 Day Avg. Volume1,483,483
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Established Historical ProfitabilityThe pre-2025 record indicates the company has previously converted business activity into profitable operations, providing evidence of an established earnings model. However, the latest reset means this strength requires validation before it can be treated as durable.
Sizable Equity BaseA sizable equity base provides some loss-absorption capacity and may support operational recovery. It does not eliminate funding risk, but it offers a more substantial balance-sheet foundation than a highly equity-constrained business.
Prior Positive Cash GenerationPositive operating and free cash flow in the four years before 2025 shows the business has previously generated internal funding. A return to that pattern could reduce reliance on external capital, although the latest reversal is a serious qualification.
Bears Say
Revenue And Margin DeteriorationThe simultaneous decline in revenue and profitability signals weaker demand, pricing, mix, or operating leverage. With EBIT margin also falling to about 6.4%, earnings resilience has materially weakened and recovery is not yet demonstrated.
Severe Cash-flow StrainDeeply negative operating and free cash flow can force the company to use cash reserves, raise funding, or slow investment. If persistent, this would constrain strategic flexibility and increase liquidity risk despite earlier positive cash generation.
Higher Financial LeverageThe sharp increase in debt relative to equity reduces financial flexibility just as earnings and cash generation have weakened. Higher leverage can amplify refinancing and interest-burden risks, limiting the company’s ability to absorb further operating pressure.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.56 and its highest was HK$11.96 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$972.89M.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Aug 31, 2026 which is in 7 days.
How were IVD Medical Holding Limited’s earnings last quarter?
IVD Medical Holding Limited released its earnings results on Mar 27, 2026. The company reported -HK$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Notavailable dividend of HK$0.062 which represents an annual dividend yield of 3.81%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
IVD Medical Holding Limited reported an EPS of -HK$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.893%.
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
320.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.45%
Trailing 12-Months
Company Description
IVD Medical Holding Limited
null
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―